Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for ISRG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
March 31, 2026 3.361B
December 31, 2025 3.030B
September 30, 2025 2.961B
June 30, 2025 2.826B
March 31, 2025 2.731B
December 31, 2024 2.415B
September 30, 2024 1.821B
June 30, 2024 1.663B
March 31, 2024 1.708B
December 31, 2023 1.814B
September 30, 2023 2.023B
June 30, 2023 1.858B
March 31, 2023 1.639B
December 31, 2022 1.491B
September 30, 2022 1.621B
June 30, 2022 1.739B
March 31, 2022 1.835B
December 31, 2021 2.089B
September 30, 2021 2.149B
June 30, 2021 1.922B
March 31, 2021 1.610B
December 31, 2020 1.485B
September 30, 2020 1.41B
June 30, 2020 1.532B
March 31, 2020 1.618B
Date Value
December 31, 2019 1.598B
September 30, 2019 1.384B
June 30, 2019 1.307B
March 31, 2019 1.223B
December 31, 2018 1.170B
September 30, 2018 1.164B
June 30, 2018 1.198B
March 31, 2018 1.183B
December 31, 2017 1.144B
September 30, 2017 1.137B
June 30, 2017 1.043B
March 31, 2017 1.076B
December 31, 2016 1.043B
September 30, 2016 1.001B
June 30, 2016 921.30M
March 31, 2016 856.70M
December 31, 2015 771.90M
September 30, 2015 682.70M
June 30, 2015 653.60M
March 31, 2015 622.50M
December 31, 2014 665.10M
September 30, 2014 700.00M
June 30, 2014 753.20M
March 31, 2014 788.30M
December 31, 2013 880.00M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Stryker Corp. 5.375B
Abbott Laboratories 9.464B
Boston Scientific Corp. 4.341B
Globus Medical, Inc. 778.51M
Edwards Lifesciences Corp. 1.359B